3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Carcinoma, Non-Small-Cell Lung
6
Neoplasms
5
Multiple Myeloma
3
Thyroid Carcinoma, Anaplastic
2
Thyroid Cancer, Papillary
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Erdheim-Chester Disease
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Pancreatic Adenocarcinoma
1
Neoplasms, Unknown Primary
1
Microsatellite Unstable Colorectal Cancer
1
Lymphoproliferative Disorders
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Laryngeal Neoplasms
1
Inflammatory Breast Neoplasms
1
Histiocytosis, Sinus
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Histiocytic Disorders, Malignant
1
Interventions
Specimen Handling
7
Biopsy
6
Cyclophosphamide
5
ruxolitinib
4
Mycophenolic Acid
4
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Tacrolimus
3
Melphalan
3
Injections
3
Decitabine
3
Cyclosporine
3
Azacitidine
3
venetoclax
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
onvansertib
1
merphos
1
iadademstat
1
gilteritinib
1
fedratinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
cobimetinib
×
1 year
×
Clear all
No trials found.